About Parhelia

Our mission is to democratize spatial biology discovery and biomarker capabilities through advanced technologies that increase accessibility, efficiency, and data quality of analytical techniques.

Parhelia Bio emerged from a shared vision at Stanford University.

As pioneers in the Spatial Biology field since its inception, we are uniquely positioned to lower the bar for anyone inspired to adopt these technologies in their research.

Co-founders Nikolay Samusik and Yury Goltsev were postdocs in the lab of Professor Garry Nolan at Stanford, where they co-developed the CODEX ultra-multiplexed spatial biology technology. They co-founded Akoya Biosciences (NASDAQ: AKYA) to commercialize CODEX (now PhenoCycler) and later acquired Opal (from Perkin Elmer) to offer critical technologies in spatial biology.

As front-line scientists pushing the boundaries of Spatial Biology, Nikolay, Yury, and Garry recognized the limitations of manual processing in preparing and staining samples for imaging analysis. Together, they founded Parhelia Biosciences to tackle these challenges head-on and enable researchers and clinicians to translate spatial biology discoveries into meaningful, biomarker-based outcome benefits for patients through reliable, consistent, and affordable automated solutions.